Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Chembiochem ; 17(9): 861-5, 2016 05 03.
Article in English | MEDLINE | ID: mdl-26812365

ABSTRACT

Mast cells and microglia play a critical role in innate immunity and inflammation and can be activated by a wide range of endogenous and exogenous stimuli. Lysophosphatidic acid (LPA) has recently been reported to activate mast cells and microglia. Using the human mast cell line HMC-1 and the mouse microglia cell line BV-2, we show that LPA-mediated activation can be prevented by blockade of the LPA receptor 5 (LPA5) in both cell lines. The identification of new LPA5-specific antagonists as tool compounds to probe and modulate the LPA5/LPA axis in relevant in vitro and in vivo assays should contribute to better understanding of the underlying role of LPAs in the development and progression of (neuro-) inflammatory diseases.


Subject(s)
Gene Expression/drug effects , Lysophospholipids/pharmacology , Receptors, Lysophosphatidic Acid/metabolism , Administration, Oral , Animals , Cell Line , Cell Membrane Permeability/drug effects , Chemokine CCL2/metabolism , Half-Life , Humans , Kinetics , Lysophospholipids/chemistry , Lysophospholipids/pharmacokinetics , Male , Mast Cells/cytology , Mast Cells/drug effects , Mast Cells/metabolism , Mice , Mice, Inbred C57BL , Microglia/cytology , Microglia/drug effects , Microglia/metabolism , Microsomes, Liver/metabolism , Receptors, Lysophosphatidic Acid/antagonists & inhibitors , Receptors, Lysophosphatidic Acid/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...